|
|
| Countries covered: China It is learned that China's hypertension morbidity rate of adults is 18.8%, treatment rate is 6.1%, and it also takes on a lowering trend of age, which attracting more and more people's attention on hypertension. Thus there is a greater demand for antihypertensive drug, and China's market scale of antihypertensive drug is still very huge in the future. This report carries out specific analysis and research of three major antihypertensive drug types, i.e.classification of current hypertension, and drug market competition. It points out that although there is a huge market demand of antihypertensive drug, the competition is still fierce. |
More China Hypertension Reports
China Hypertension Prescription Drug Sales Data 2007-2010 by
Draco Healthcare Consulting LLC
The series of China Prescription Drug (CPD) sales reports have systemically analyzed Chinese prescription drug market, according to different therapeutic areas. All market estimates ...
Chinese Markets for Hypertension Drugs by
Asia Market Information & Development Company
China's demand for Hypertension Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand ...
See all reports like this >>
More China Reports
D&B Country RiskLine Report: China by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
Country Report China February 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Country Report China January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
D&B Country Report: China by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Wine - BRIC (Brazil, Russia, India, China) Industry Guide by
MarketLine
Datamonitor's Wine - BRIC (Brazil, Russia, India, China) Industry Guide is an essential resource for top-level data and analysis covering the BRIC (Brazil, Russia, India, ...
See all reports like this >>
Related Markets
Hypertension Reports
- Pulmonary Arterial Hypertension (PAH) Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020
- Anti-Hypertensives Market to 2017 - Patent Expiries of Blockbusters such as Diovan, Micardis, Avapro and Atacand to Accelerate Erosion
- Portal Hypertension Therapeutics - Pipeline Assessment and Market Forecasts to 2019
- Hypertension Global Clinical Trials Review, H1, 2012
- Pulmonary Hypertension Global Clinical Trials Review, H1, 2012
